Evidence map›Paper›PMID 34634579›Full record

ArticleSexual medicine2021

Comorbidity Prevalence and Impact on Quality of Life in Gay and Bisexual Men Following Prostate Cancer Treatment.

Ryan Haggart, Elizabeth Polter, Michael Ross, Nidhi Kohli, Badrinath R Konety, Darryl Mitteldorf, William West, B R Simon Rosser

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Sexual medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Review
  3. "Ultimately, You Realize You're on Your Own": The Impact of Prostate Cancer on Gay and Bisexual Men Couples.International journal of environmental research and public health · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Ryan HaggartDepartment of Urology, University of Minnesota, Minneapolis, MN, USA. Electronic address: rhaggart@umn.edu.
Elizabeth PolterDivision of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Michael RossDepartment of Family Medicine & Community Health, Medical School, University of Minnesota, Minneapolis, MN, USA.
Nidhi KohliDepartment of Educational Psychology, University of Minnesota, Minneapolis, MN, USA.
Badrinath R KonetyRush Medical College, Rush University, Chicago, IL, USA.
Darryl MitteldorfMalecare Cancer Support, New York NY, USA.
William WestDepartment of Writing Studies, University of Minnesota, Minneapolis, MN, USA.
B R Simon RosserDivision of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
University of Minnesota · USCancerCare · USMinnesota Department of Education · USMinnesota Department of Health · USRush University · USUniversity of Wisconsin–Madison · US

Funding

Understanding the Effects of Prostate Cancer on Gay and Bisexual MenR21CA182041 · NCI · UNIVERSITY OF MINNESOTA · PI ROSSER, B R SIMON · 2014 to 2015
$331k
NCI NIH HHS R21 CA182041
6 · The paper itself

Abstract

introductionStudies have demonstrated worse health related quality of life (HRQOL) outcomes in gay and bisexual men (GBM) following prostate cancer treatment compared to heterosexual men potentially due to differences in comorbidity burden.

aimTo establish the prevalence of comorbidities and their association with HRQOL metrics in GBM following prostate cancer treatment.

methodsWe evaluated HRQOL and prevalence of comorbidities in 193 GBM from the United States and Canada in a cross-sectional, online survey: the Masked for Review. HRQOL was measured with the Expanded Prostate Cancer Index Composite (EPIC) and the 12-Item Short Form Health Survey (SF-12).

main outcome measuresOur outcomes included comorbidity prevalence, mean differences for HRQOL scores by comorbidity status, and mean differences for HRQOL by comorbidity count.

resultsGBM were found to have a higher prevalence of blood vessel disease and mental health disorders but lower prevalence of obesity and type 2 diabetes when compared to published data in general prostate cancer populations. Statistically significant reductions in HRQOL metrics were associated with mental health diagnoses, diabetes, and obesity. Increased number of comorbidities was also associated with reductions in HRQOL metrics in nearly all categories.

conclusionThese results suggest that the worse QOL outcomes in GBM following prostate cancer treatment may be due to differences in comorbidity burden. This study is the first to evaluate the relationship between comorbidities and HRQOL outcomes in GBM. Limitations of this study include a small sample size and cross-sectional study design. If confirmed in larger, longitudinal, clinically confirmed studies, these findings indicate a need to intervene on and consider comorbidities in GBM diagnosed with prostate cancer. Haggart R, Polter E, Ross M, et al. Comorbidity Prevalence and Impact on Quality of Life in Gay and Bisexual Men Following Prostate Cancer Treatment. Sex Med 2021;9:100439.

Indexed as

Bisexual MenEPICGay MenHealth Related Quality of LifeHomosexual MenProstate CancerSF12

Identifiers

PMID34634579
PMCPMC8766256
OpenAlexW3205435448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.